Partners in Digital Health

por Tory Cenaj

Partners in Digital Health (PDH) is a forward-reaching media and communications company, catalyzing strategic thoughts-leaders, and new era thinkers that champion the acceleration of healthcare transformation. The portfolio converges leading academics, pragmatic innovators, and practitioners around the globe to assist in the acceleration of healthcare transformation, and better outcomes for health consumers presenting evidence  ...   ...  Leer más

Episodios del podcast

  • Temporada 6

  • Rebel Patients and Caregivers Podcast – Part II

    Rebel Patients and Caregivers Podcast – Part II

    Rebel Patients and Caregivers Podcast – Part II Susannah Fox, Author - Rebel Health: A Field Guide to the Patient-Led Revolution in Medical Care, USA Paul Barach, MD - Chief Medical Officer, Pegwin, USA Sarah Bell, RN, MSN, MHA - Former Vice President, Product and Clinical Evaluation, Biofourmis, USA Inspiring patients are creating solutions and setting new standards for what’s possible in health and outcomes. In Part II of THMT’s Rebel Health podcast, anyone working inside healthcare who is fed up with the status quo, and ready to create change, should listen. The discussion is raw, bold and honest – all to improve health outcomes, keep people safe, find effective treatments. If you need an ally and strategies, Rebels are standing by to help including Telehealth and Medicine Today. Discussion Topics Outlining steps for patients, caregivers, and survivors to tap into the innovative ecosystem outside of traditional healthcare. How healthcare has fallen short in addressing the needs of patients with rare conditions? What are some of the challenges that clinicians are facing when they come across patients who have rare or unexplained conditions? Has mainstream healthcare abandoned its workforce? The evolution successful early grassroots groups and how they became part of mainstream medicine? Has a lack of transformation in healthcare (clipboards, fax machines, and retro software) influenced the patient-led revolution and helped expedite progress in this space? Where do healthcare professionals fit in this revolution? Thoughts on actions listeners can take?

  • AI Governance in Healthcare: Best Practices, Solutions, and Unresolved Issues

    AI Governance in Healthcare: Best Practices, Solutions, and Unresolved Issues

    AI Governance in Healthcare: Best Practices, Solutions, and Unresolved Issues Calvin Lawrence - Distinguished Engineer – Responsible AI , Member of AI Ethics Board and Academy of Technology, IBM Seth Dobrin, PhD - Founder and CEO, Qantm AI Gil Alterovitz, PhD - Director, Biomedical Cybernetics Laboratory Harvard Medical School, Member of CHAI Yoav Schlesinger - Architect, Ethical AI Practice, Healthcare Salesforce Moderator: Dennis Chornenky - Chief AI Advisor UC Davis Health and CEO, Domelabs AI What challenges are presented by AI adoption in healthcare? What role should AI governance play in regard to the opportunities and risks for generative AI (large language models like ChatGPT-4, etc.) in health? How do we responsibly evaluate new technology and ensure guardrails for its deployment, but without stifling innovation? How do we address societal fears and biases? What level of reliability and robustness should algorithms achieve before being adopted with confidence across healthcare? How can AI support health equity and expand access?

  • Creating a Health Data Marketplace for the Digital Health Era

    Creating a Health Data Marketplace for the Digital Health Era

    Creating a Health Data Marketplace for the Digital Health Era Imtiaz Khan, PhD - Associate Professor of Data Science, Cardiff School of Technologies, Cardiff Metropolitan University Mohamed A. Maher - MedTech Entrepreneur and Director of Innovation at Balsamee LTD Moderator: Anjum Khurshid, PhD - Associate Professor, Harvard Medical School, and Chief Data Scientist, Sentinel Operations Center, a Harvard Pilgrim HealthCare Institute With the advent of the General Data Protection Regulation (GDPR) of the EU and the development of technologies like blockchain and distributed ledger technologies (DLT), it is now possible to create a new paradigm with a shared economic model where financial Incentivization will be the main driver for data sharing. This can be achieved by setting up a digital health data marketplace (DHDM). Speakers on s podcast authored a paper in BTHY journal entitled “From Sharing to Selling: Challenges and Opportunities of Establishing a Digital Health Data Marketplace Using Blockchain Technologies,” https://doi.org/10.30953/bhty.v5.184 Their ongoing work is discussed for the DHDM operation outlined along with current developments and future work. Questions addressed are below: What inspired the authors to explore the use of blockchain technology in healthcare data sharing and monetization? What are the key challenges and opportunities identified in establishing a digital health data marketplace using blockchain technologies? What are the potential socioeconomic impacts of a digital health data marketplace on patients, healthcare providers, and researchers, and how do you see the economics of health data developing into dynamic systems that will reflect in the processes of care delivery and management? What are the next steps for the research? Are there ongoing projects or collaborations the audience can expect to be excited about?

  • Temporada 5

  • Challenges in Digital Health: from Telemedicine to AI

    Challenges in Digital Health: from Telemedicine to AI

    Challenges in Digital Health: from Telemedicine to AI Claudio Alves da Costa, MD, MSc, PhD, CPHIMS Gustavo Meirelles | Chairman of the Board, iDr Moderator: Jefferson G. Fernandes, MD | Vice President, AMP – Brazil Telehealth and Telemedicine Association In this ConV2X 2023 panel session, speakers address relevant aspects of the use of artificial intelligence in telemedicine, the opportunities, and threats of AI in health, and the assessment of the digital maturity of organizations. Experiences and views on these topics will guide the presentations.

  • Soulbound Tokens: Enabler for Privacy-Aware and Decentralized Authentication Mechanism in Medical Data Storage

    Soulbound Tokens: Enabler for Privacy-Aware and Decentralized Authentication Mechanism in Medical Data Storage

    Soulbound Tokens: Enabler for Privacy-Aware and Decentralized Authentication Mechanism in Medical Data Storage Imtiaz Khan, PhD | Associate Professor of Data Science, Cardiff School of Technologies, Cardiff Metropolitan University Mohamed A. Maher | MedTech Entrepreneur and Director of Innovation at Balsamee LTD Moderator: Anjum Khurshid, PhD | Associate Professor, Harvard Medical School, and Chief Data Scientist, Sentinel Operations Center, a Harvard Pilgrim HealthCare Institute With the advent of the General Data Protection Regulation (GDPR) of the EU and the development of technologies like blockchain and distributed ledger technologies (DLT), it is now possible to create a new paradigm with a shared economic model where financial Incentivization will be the main driver for data sharing. This can be achieved by setting up a digital health data marketplace (DHDM). Speakers on s podcast authored a paper in BTHY journal entitled “From Sharing to Selling: Challenges and Opportunities of Establishing a Digital Health Data Marketplace Using Blockchain Technologies,” https://doi.org/10.30953/bhty.v5.184 Their ongoing work is discussed for the DHDM operation outlined along with current developments and future work. Questions addressed are below: What inspired the authors to explore the use of blockchain technology in healthcare data sharing and monetization? What are the key challenges and opportunities identified in establishing a digital health data marketplace using blockchain technologies? What are the potential socioeconomic impacts of a digital health data marketplace on patients, healthcare providers, and researchers, and how do you see the economics of health data developing into dynamic systems that will reflect in the processes of care delivery and management? What are the next steps for the research? Are there ongoing projects or collaborations the audience can expect to be excited about?